Canada markets closed

MindBio Therapeutics Corp. (MBIO.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.0700+0.0100 (+16.67%)
At close: 03:03PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 7.98M
Enterprise Value 12.40M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)44.78
Price/Book (mrq)N/A
Enterprise Value/Revenue 69.51
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-50.00%
S&P500 52-Week Change 326.16%
52 Week High 30.1400
52 Week Low 30.0150
50-Day Moving Average 30.0574
200-Day Moving Average 30.0416

Share Statistics

Avg Vol (3 month) 344.19k
Avg Vol (10 day) 333.42k
Shares Outstanding 5133.05M
Implied Shares Outstanding 6133.05M
Float 8125.81M
% Held by Insiders 111.11%
% Held by Institutions 10.00%
Shares Short (Apr 15, 2024) 432.93k
Short Ratio (Apr 15, 2024) 40.1
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.02%
Shares Short (prior month Mar 15, 2024) 46.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)42.18%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)630.65k
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-3.55M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)260.2k
Total Cash Per Share (mrq)0
Total Debt (mrq)5.07M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.20
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-968.58k
Levered Free Cash Flow (ttm)N/A